Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2494
-0.0017(-0.13%)
Bitcoin GBP
51,112.48
-628.84(-1.22%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Charles River Laboratories International, Inc. (CRL)

NYSE - NYSE Delayed price. Currency in USD

Add to watchlist

229.03

+1.22

(+0.54%)

At close: 04:00PM EDT

229.03

0.00

(0.00%)

After hours:

05:59PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	11.73B
Enterprise value	14.52B
Trailing P/E	24.71
Forward P/E	20.83
PEG ratio (5-yr expected)	1.77
Price/sales (ttm)	2.84
Price/book (mrq)	3.26
Enterprise value/revenue	3.52
Enterprise value/EBITDA	14.07

Trading information

Stock price history

Beta (5Y monthly)	1.41
52-week change ³	19.82%
S&P500 52-week change ³	21.08%
52-week high ³	275.00
52-week low ³	161.65
50-day moving average ³	253.29
200-day moving average ³	216.39

Share statistics

Avg vol (3-month) ³	541.4k
Avg vol (10-day) ³	543.17k
Shares outstanding ⁵	51.51M
Implied shares outstanding ⁶	51.51M
Float ⁸	50.74M
% held by insiders ¹	0.98%
% held by institutions ¹	103.12%
Shares short (15 Apr 2024) ⁴	1.91M
Short ratio (15 Apr 2024) ⁴	4.18
Short % of float (15 Apr 2024) ⁴	4.81%
Short % of shares outstanding (15 Apr 2024) ⁴	3.70%
Shares short (prior month 15 Mar 2024) ⁴	1.59M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	30 Dec 2023
Most-recent quarter (mrq)	30 Dec 2023

Profitability

Profit margin	11.49%
Operating margin (ttm)	14.52%

Management effectiveness

Return on assets (ttm)	5.19%
Return on equity (ttm)	14.38%

Income statement

Revenue (ttm)	4.13B
Revenue per share (ttm)	80.61
Quarterly revenue growth (yoy)	-7.90%
Gross profit (ttm)	N/A
EBITDA	970.29M
Net income avi to common (ttm)	474.62M
Diluted EPS (ttm)	9.23
Quarterly earnings growth (yoy)	-0.20%

Balance sheet

Total cash (mrq)	276.77M
Total cash per share (mrq)	5.39
Total debt (mrq)	3.13B
Total debt/equity (mrq)	85.46%
Current ratio (mrq)	1.52
Book value per share (mrq)	70.06

Cash flow statement

Operating cash flow (ttm)	683.9M
Levered free cash flow (ttm)	218.76M